Preferred Name |
brinzolamide |
|
Synonyms |
(R)-4-(ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-2H-thieno(3,2-E)-1,2-thiazine-6-sulfonamide 1,1-dioxide |
|
ID |
http://purl.bioontology.org/ontology/MESH/C111827 |
|
altLabel |
(R)-4-(ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-2H-thieno(3,2-E)-1,2-thiazine-6-sulfonamide 1,1-dioxide 2H-thieno(3,2-E)-1,2-thiazine-6-sulfonamide, 4-(ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-, 1,1-dioxide, (R)- Azopt |
|
cui |
C0673967 C0673966 |
|
HM |
D013843 D013449 |
|
Inverse of RB |
9451Z89515 |
|
isa | ||
LT |
TRD |
|
Mapped to | ||
MDA |
19980511 |
|
MeSH Frequency |
231 |
|
MMR |
20161222 |
|
notation |
C111827 |
|
PA |
D002257 |
|
prefLabel |
brinzolamide |
|
RR |
138890-62-7 |
|
SC |
1 |
|
Scope Statement |
an antiglaucoma agent |
|
SRC |
Protein Sci 1998 Mar;7(3):556-63 |
|
TERMUI |
T319421 T319420 T000913137 |
|
TH |
US UK NL CA ES USAN (19XX) INN (19XX) DE AU NLM (1998) FDA SRS (2015) NLM (2017) FR IE |
|
tui |
T109 T121 |
Create mapping